Johnson & Johnson is comprised of several subsidiaries that each report information separately. The subsidiaries in Dollars for Docs include Janssen Pharmaceuticals (the largest), Janssen Therapeutics, Janssen Biotech and Janssen Global Services. The units began reporting payments made in 2010 for speaking, consulting, post-marketing safety surveillance, meals and travel.
Each subsidiary reports on a different schedule, but in Dollars for Docs the payments are grouped together as Johnson & Johnson. The subsidiary is listed within each payment page.Merck began reporting payments to health professionals for speaking as of July 2009. Its report included the number of events and the topic areas covered. Its 2011 report limited its disclosure of those payments to physicians only. The 2011 report included for the first time speaking activities related to companies it acquired, including Schering Plough and Inspire Pharmaceuticals.
See all Johnson & Johnson payments, or visit Johnson & Johnson's transparency page.
Notable drugs
Notable drugs from Janssen Biotech,
a subsidiary of Johnson & Johnson
- Remicade (plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, crohn's disease/pediatric crohn's disease, ankylosing spondylitis, ulcerative colitis/pediatric ulcerative colitis)
- Procrit (anemia, reduction of allogeneic red blood cell transfusions in patients undergoing elective, noncardiac, nonvascular surgery)
- Stelara (plaque psoriasis)
- Simponi (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis)
- Zytiga (prostate cancer)
Notable drugs from Janssen Pharmaceuticals,
a subsidiary of Johnson & Johnson
- Risperdal Consta (antipsychotic for schizophrenia and bipolar i disorder)
- Concerta (adhd)
- Aciphex (acid reflux, heartburn)
- Levaquin (antibiotic for pneumonia, acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, skin and skin structure infections: complicated and uncomplicated, chronic bacterial prostatitis, urinary tract infections: complicated and uncomplica)
- Invega Extended-Release Tablets (schizophrenia, schizoaffective disorder)
- Invega Sustenna (schizophrenia)
- Nucynta (painkiller)
- Nucynta ER (painkiller)
- Ortho Evra (contraceptive)
- Ortho Tri-Cyclen Lo (contraceptive)
- Topamax (epilepsy, migraines)
- Xarelto (reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, deep vein thrombosis, pulmonary embolism)
- Duragesic CII (painkiller)
- Ultram/Ultram ER (painkiller)
Notable drugs from Janssen Therapeutics,
a subsidiary of Johnson & Johnson
Payment Reports
2010 Jan. to 2011 Dec., Janssen Global Services
|
Avg. Quarterly |
Total |
| Consulting |
$140,860 |
$140,860 |
|
$140,860 |
$140,860 |
2010 Jan. to Dec. Janssen Biotech
|
Avg. Quarterly |
Total |
| Speaking |
$725,175 |
$2,900,700 |
| Consulting |
$156,047 |
$624,187 |
| Other |
$44,204 |
$176,816 |
|
$925,426 |
$3,701,703 |
2010 Jan. to Dec. Janssen Pharmaceuticals
|
Avg. Quarterly |
Total |
| Speaking |
$1,684,425 |
$6,737,700 |
| Combination |
$637,544 |
$2,550,175 |
| Travel |
$393,540 |
$1,574,160 |
| Consulting |
$205,318 |
$821,272 |
| Meals |
$66,128 |
$264,512 |
| Other |
$2,175 |
$8,700 |
|
$2,989,130 |
$11,956,519 |
2010 Jan. to Dec. Janssen Therapeutics
|
Avg. Quarterly |
Total |
| Speaking |
$500,125 |
$2,000,500 |
| Consulting |
$84,125 |
$336,500 |
|
$584,250 |
$2,337,000 |
2011 Jan. to Dec. Janssen Biotech
|
Avg. Quarterly |
Total |
| Speaking |
$1,258,763 |
$5,035,050 |
| Consulting |
$323,010 |
$1,292,039 |
| Other |
$23,024 |
$92,097 |
|
$1,604,796 |
$6,419,186 |
2011 Jan. to Dec. Janssen Pharmaceuticals
|
Avg. Quarterly |
Total |
| Speaking |
$1,579,769 |
$6,319,075 |
| Meals |
$1,101,540 |
$4,406,159 |
| Consulting |
$486,550 |
$1,946,201 |
| Travel |
$338,025 |
$1,352,098 |
| Other |
$3,355 |
$13,419 |
|
$3,509,238 |
$14,036,952 |
2011 Jan. to Dec. Janssen Therapeutics
|
Avg. Quarterly |
Total |
| Speaking |
$682,188 |
$2,728,750 |
| Consulting |
$49,038 |
$196,150 |
|
$731,225 |
$2,924,900 |
2012 Jan. to Sept. Janssen Pharmaceuticals
|
Avg. Quarterly |
Total |
| Speaking |
$2,388,300 |
$7,164,900 |
| Meals |
$1,342,883 |
$4,028,648 |
| Consulting |
$321,900 |
$965,700 |
| Travel |
$309,552 |
$928,655 |
|
$4,362,635 |
$13,087,904 |
